Companies: 10,795·Total market cap: $144.5T
Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited

PLSIOTCHealthcare
$0.00
$-0.82(-99.99%)
Market Cap$365910
P/E Ratio—
52W High—
52W Low—
SEC Filings

Phoenix Life Sciences International Limited (PLSI) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001493212 · PLSI · OTC · as of Jun 9, 2026

Filing snapshot

137
Total Filings
REVOKED
Latest Form
2023-11-16
Most Recent
2011
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001493212 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2020-04-10
Fiscal Year End
Apr 10, 2020
Accession No.
0001078782-20-000245
Primary Document
f10k022819_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001493212 · Accession 0001078782-20-000245

Latest Key Filings

10-QQuarterly Report
QUARTERLY REPORT
2019-05-24
View 10-Q on SEC
8-KCurrent Report
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED. (FORM: 8-K, RECEIVED: 08/29/2019 16
2020-11-20Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
REVOKEDREVOKED
REVOKED
2023-11-16
View
8-KCurrent Report
PHOENIX LIFE SCIENCES INTERNATIONAL LIMITED. (FORM: 8-K, RECEIVED: 08/29/2019 16
2020-11-20
View
10-KAnnual Report
FORM 10-K ANNUAL REPORT
2020-04-10
View
8-KCurrent Report
CURRENT REPORT
2019-08-29
View
8-KCurrent Report
CURRENT REPORT
2019-08-09
View
8-KCurrent Report
CURRENT REPORT
2019-07-11
View
8-KCurrent Report
CURRENT REPORT
2019-06-28
View
8-A12G8-A12G
FORM 8-A12G
2019-06-14
View
8-KCurrent Report
CURRENT REPORT
2019-06-11
View
NT 10-KNT 10-K
NOTICE OF INABILITY TO TIMELY FILE
2019-05-31
View
10-QQuarterly Report
QUARTERLY REPORT
2019-05-24
View
DD
D
2019-04-30
View
10-QQuarterly Report
QUARTERLY REPORT
2019-04-25
View
10-QQuarterly Report
QUARTERLY REPORT
2019-04-25
View
10-KAnnual Report
ANNUAL REPORT
2019-04-22
View
Showing 1–15 of 137 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001493212  |  Exchange: OTC · Healthcare

Phoenix Life Sciences International Limited (OTC: PLSI) has submitted 137 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2011. As a Healthcare sector company with CIK 0001493212, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Phoenix Life Sciences International Limited's most comprehensive regulatory disclosure. The most recent Phoenix Life Sciences International Limited 10-K was filed on 2020-04-10 for fiscal year ending 2020. Historical PLSI 10-K annual reports are available from 2010 through 2020.

Investors researching Phoenix Life Sciences International Limited SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
→ PLSI Financials→ PLSI Earnings→ PLSI Insider Trades

Frequently Asked Questions

PLSI SEC Filings · 8 questions

Phoenix Life Sciences International Limited (PLSI) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 137 filings and access original documents at no cost. Phoenix Life Sciences International Limited's CIK is 0001493212.

PLSI SEC filingsPhoenix Life Sciences International Limited SEC documentsfind PLSI 10-K